Advertisement
Brief rapid report| Volume 27, ISSUE 6, P682-684, November 2011

Download started.

Ok

Clinical Implications of Direct-to-Consumer Genetic Testing for Cardiovascular Disease Risk

      Abstract

      Direct-to-consumer (DTC) genetic testing for cardiovascular disease (CVD) is becoming increasingly accessible due to technological advances, falling prices, and assertive marketing. However, information to guide physicians and patients on how to interpret or react clinically to DTC genetic test results is scarce. We report the case of a 52-year-old man with a family history of CVD who had DTC genetic testing performed. We discuss selected results and interpretation of this testing and the outcome of subsequent lifestyle interventions. Despite the information this new technology seemed to provide, traditional advice on lifestyle modification was central to his management.

      Résumé

      Les tests génétiques directement aux consommateurs (DAC) pour les maladies cardiovasculaires (MCV) sont de plus en plus accessibles en raison des avancées technologiques, de la chute des prix et du marketing dynamique. Cependant, l'information pour guider les médecins et les patients sur la manière d'interpréter ou de réagir cliniquement aux tests génétiques DAC est peu abondante. Nous rapportons le cas d'un homme de 52 ans avec des antécédents familiaux de MCV qui avait réalisé un test génétique DAC. Nous discutons des résultats sélectionnés et de l'interprétation de ce test ainsi que du résultat des interventions au mode de vie subséquent. En dépit de l'information que cette nouvelle technologie semble fournir, des conseils traditionnels sur la modification du mode de vie étaient au cœur de sa gestion.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Canadian Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • The Framingham Heart Study
        General cardiovascular disease (10-year risk).
        (Accessed August 17, 2010)
        • Frayling T.M.
        • Timpson N.J.
        • Weedon M.N.
        • et al.
        A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity.
        Science. 2007; 316: 889-894
      1. 23andMe. Health and traits: obesity. Disease risk. Accessed December 17, 2010 (not freely accessible).

        • Willer C.J.
        • Speliotes E.K.
        • Loos R.J.
        • et al.
        Six new loci associated with body mass index highlight a neuronal influence on body weight regulation.
        Nat Genet. 2009; 41: 25-34
        • McPherson R.
        • Pertsemlidis A.
        • Kavaslar N.
        • et al.
        A common allele on chromosome 9 associated with coronary heart disease.
        Science. 2007; 316: 1488-1491
        • Ripatti S.
        • Tikkanen E.
        • Orho-Melander M.
        • et al.
        A multilocus genetic risk score for coronary heart disease: case-control and prospective cohort analyses.
        Lancet. 2010; 376: 1393-1400
        • Li S.
        • Zhao J.H.
        • Luan J.
        • et al.
        Physical activity attenuates the genetic predisposition to obesity in 20,000 men and women from EPIC-Norfolk prospective population study.
        PLoS Med. 2010; 7: 1-9